Merck have just finished giving evidence to a full day meeting of the US FDA in pursuit of getting and Emergency Use Approval for Molnupiravir. They slightly played down the fact that it didn't really show much of an improvement in the second half of the trial (i.e. after they announced how good it was an governments flocked to buy it) but the stuff about malformations in rats has been talked about.
I don't really see how a govt could approve this for widespread use.
The meeting is still live at www.youtube.com/watch?app=desktop&v=fR9FNSJT64M if anyone is interested but it's pretty dull really.
|